A Delphi-method-based consensus for clinical domains and assessment of the inflammatory subtype of major depressive disorder from the ASPIRE study

Source
Brain, behavior, and immunity - ISSN 0889-1591-138 (2026) p.
Author(s)
    Benedetta Vai, Tommaso Cazzella, Camilla Monopoli, Beatrice Bravi, Anastasia Kontogianni, Céline Wessa, Courtney Worrell, Maria S. Simon, Bernhard T. Baune, Francesco Benedetti, Annamaria Cattaneo, Erik Van der Eycken, Jennifer C. Felger, Stefan M. Gold, Neil A. Harrison, Nadia Hoffman, Femke Lamers, Marion Leboyer, Giulia Lombardo, Fanni-Laura Mantyla, Andrew H. Miller, Valeria Mondelli, Brenda W.J.H. Penninx, Dan Stein, Luca Sforzini, Francesco Bavato, Michael Berk, Alessandra Borsini, Igor Branchi, Lucile Capuron, Javier R. Caso, Janet L. Cunningham, Paolo Fusar-Poli, Bartholomeus C.M. Haarman, Aiste Lengvenyte, Emanuele F. Osimo, Christian Otte, Thomas A. Pollak, Nils Eiel Steen, Carmine M. Pariante, Livia De Picker

Current evidence on immune-driven depression

Source
Current opinion in psychiatry - ISSN 0951-7367-39:1 (2026) p. 8-18
Author(s)

Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder : protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial

Source
Brain, behavior, & immunity - health - ISSN 2666-3546-41 (2024) p. 1-7
Author(s)

Choice of outcome measure predicts anti-inflammatory treatment efficacy in major depressive disorder

Source
Neuropsychiatric Disease and Treatment - ISSN 1178-2021-19 (2023) p. 515-517